eli lilly gip/glp-1 Lilly's diabetes drug Mounjaro receives expanded approval for weight management in Korea < Pharma < Article Eli Lilly just made history
Description
Gq-mER signaling has opposite effects on hypothalamic orexigenic and anorexigenic neurons
doi: 10.1016/S2213-8587(23)00356-X
Glycine itself has a mild calming quality, which is part of why this form is associated with better sleep
The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status
GLP-1 : Does It Really Work
Feng X et al
